BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17512803)

  • 21. Wiskott-Aldrich Syndrome causing mutation, Pro373Ser restricts conformational changes essential for WASP activity in T-cells.
    Jain N; George B; Thanabalu T
    Biochim Biophys Acta; 2014 Apr; 1842(4):623-34. PubMed ID: 24440360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
    Blundell MP; Worth A; Bouma G; Thrasher AJ
    Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical requirement for the Wiskott-Aldrich syndrome protein in Th2 effector function.
    Morales-Tirado V; Sojka DK; Katzman SD; Lazarski CA; Finkelman FD; Urban JF; Fowell DJ
    Blood; 2010 Apr; 115(17):3498-507. PubMed ID: 20032499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.
    Sasahara Y
    Pediatr Int; 2016 Jan; 58(1):4-7. PubMed ID: 26331277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wiskott-Aldrich Syndrome in four male siblings from a consanguineous family from Lebanon.
    Mansour R; El-Orfali Y; Saber A; Noun D; Youssef N; Youssef Y; Hanna-Wakim R; Dbaibo G; Abboud M; Massaad MJ
    Clin Immunol; 2020 Oct; 219():108573. PubMed ID: 32814211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wiskott-Aldrich syndrome protein: Emerging mechanisms in immunity.
    Rivers E; Thrasher AJ
    Eur J Immunol; 2017 Nov; 47(11):1857-1866. PubMed ID: 28805251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein.
    Nikolov NP; Shimizu M; Cleland S; Bailey D; Aoki J; Strom T; Schwartzberg PL; Candotti F; Siegel RM
    Blood; 2010 Aug; 116(5):740-7. PubMed ID: 20457871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wiskott-Aldrich syndrome protein may be critical for CD8
    Li S; Huang J; Zhang YL; Zhu Y; An YF; Du J; Zhang ZL; Xia Y; Liu L; Wang L; Luo XH
    Cell Immunol; 2019 Apr; 338():43-50. PubMed ID: 30981413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs.
    Trifari S; Scaramuzza S; Catucci M; Ponzoni M; Mollica L; Chiesa R; Cattaneo F; Lafouresse F; Calvez R; Vermi W; Medicina D; Castiello MC; Marangoni F; Bosticardo M; Doglioni C; Caniglia M; Aiuti A; Villa A; Roncarolo MG; Dupré L
    J Allergy Clin Immunol; 2010 Feb; 125(2):439-448.e8. PubMed ID: 20159256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of zinc-finger nucleases to knock out the WAS gene in K562 cells: a human cellular model for Wiskott-Aldrich syndrome.
    Toscano MG; Anderson P; Muñoz P; Lucena G; Cobo M; Benabdellah K; Gregory PD; Holmes MC; Martin F
    Dis Model Mech; 2013 Mar; 6(2):544-54. PubMed ID: 23324327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome.
    Taylor MD; Sadhukhan S; Kottangada P; Ramgopal A; Sarkar K; D'Silva S; Selvakumar A; Candotti F; Vyas YM
    Sci Transl Med; 2010 Jun; 2(37):37ra44. PubMed ID: 20574068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity.
    Becker-Herman S; Meyer-Bahlburg A; Schwartz MA; Jackson SW; Hudkins KL; Liu C; Sather BD; Khim S; Liggitt D; Song W; Silverman GJ; Alpers CE; Rawlings DJ
    J Exp Med; 2011 Sep; 208(10):2033-42. PubMed ID: 21875954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy.
    Lexmond WS; Goettel JA; Lyons JJ; Jacobse J; Deken MM; Lawrence MG; DiMaggio TH; Kotlarz D; Garabedian E; Sackstein P; Nelson CC; Jones N; Stone KD; Candotti F; Rings EH; Thrasher AJ; Milner JD; Snapper SB; Fiebiger E
    J Clin Invest; 2016 Oct; 126(10):4030-4044. PubMed ID: 27643438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired T-cell priming in vivo resulting from dysfunction of WASp-deficient dendritic cells.
    Bouma G; Burns S; Thrasher AJ
    Blood; 2007 Dec; 110(13):4278-84. PubMed ID: 17673604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
    Ochs HD
    Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice.
    Recher M; Burns SO; de la Fuente MA; Volpi S; Dahlberg C; Walter JE; Moffitt K; Mathew D; Honke N; Lang PA; Patrizi L; Falet H; Keszei M; Mizui M; Csizmadia E; Candotti F; Nadeau K; Bouma G; Delmonte OM; Frugoni F; Fomin AB; Buchbinder D; Lundequist EM; Massaad MJ; Tsokos GC; Hartwig J; Manis J; Terhorst C; Geha RS; Snapper S; Lang KS; Malley R; Westerberg L; Thrasher AJ; Notarangelo LD
    Blood; 2012 Mar; 119(12):2819-28. PubMed ID: 22302739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding.
    Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS
    J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wiskott-Aldrich syndrome.
    Notarangelo LD; Miao CH; Ochs HD
    Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of highly polymorphic T cell populations in siblings with the Wiskott-Aldrich Syndrome.
    Lutskiy MI; Park JY; Remold SK; Remold-O'Donnell E
    PLoS One; 2008; 3(10):e3444. PubMed ID: 18941616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.